• Thumbnail for Fingolimod
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate...
    27 KB (2,539 words) - 05:53, 26 March 2024
  • Thumbnail for Sphingosine-1-phosphate receptor modulator
    secondary lymphs. Furthermore, fingolimod was found to modulate receptors 1-5 of the sphingosine-1-phosphate class. Fingolimod is the first-in-class discovered...
    14 KB (1,581 words) - 16:44, 1 February 2024
  • Sphingolipidoses General structures of sphingolipids Dimethylsphingosine Fingolimod Radin N (2003). "Killing tumours by ceramide-induced apoptosis: a critique...
    4 KB (219 words) - 13:26, 11 May 2024
  • Thumbnail for Diethyl acetamidomalonate
    pharmaceutical formulations, particularly in the cases of active ingredients like fingolimod, which is used to treat multiple sclerosis. A notable method for synthesizing...
    10 KB (994 words) - 06:26, 12 November 2023
  • Thumbnail for Ozanimod
    established through the clinical work performed during development of fingolimod (trade name Gilenya), a non‐selective S1P modulator.[better source needed]...
    33 KB (3,240 words) - 13:34, 27 January 2024
  • fumarate itself, (Bafiertam), approved in April 2020. Four S1P modulators: Fingolimod (Gilenya), an oral treatment and the first oral therapy approved for multiple...
    83 KB (9,409 words) - 23:31, 26 April 2024
  • Thumbnail for Ceramide
    5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
    29 KB (3,310 words) - 03:20, 2 February 2024
  • Thumbnail for Demyelinating disease
    remyelination after injury or disease. Immunomodulatory drugs such as fingolimod have been shown to reduce immune-mediated damage to the CNS, preventing...
    24 KB (2,701 words) - 21:14, 9 March 2024
  • Thumbnail for Progressive multifocal leukoencephalopathy
    during a 4-year course of dimethyl fumarate, developed PML and died. Fingolimod (Gilenya) was approved in 2010 by the FDA for MS. In 2015, the first case...
    23 KB (2,414 words) - 19:20, 9 February 2024
  • degeneration. There are 5 types of Sphingosine-1-phosphate receptor. The drug fingolimod (FTY720), which agonizes the S1P receptor, prevents autoimmune lymphocytes...
    24 KB (2,604 words) - 16:08, 19 March 2024
  • in Penicillium stoloniferum. Thermophilic fungi were the source of the fingolimod precursor myriocin. Aspergillus synthesizes immunosuppressants gliotoxin...
    19 KB (1,718 words) - 19:43, 22 April 2024
  • Thumbnail for Multiple sclerosis
    roughly equivalent to that of adults. The role of some newer agents such as fingolimod, teriflunomide, and dimethyl fumarate, is not yet entirely clear. Making...
    164 KB (17,366 words) - 22:18, 9 May 2024
  • Thumbnail for Novartis
    Galvus (vildagliptin) Diabetes mellitus type 2 910 2012 39% Gilenya (fingolimod) Multiple sclerosis 1,195 2012 142% Gleevec/Glivec (imatinib) Oncology...
    142 KB (11,963 words) - 08:25, 3 May 2024
  • Thumbnail for Myriocin
    potent than ciclosporin.[citation needed] The multiple sclerosis drug fingolimod was derived from myriocin by using structure–activity relationship studies...
    4 KB (162 words) - 17:25, 1 March 2024
  • Thumbnail for Immunosuppressive drug
    in combination with ciclosporin or tacrolimus in transplant patients. Fingolimod is a synthetic immunosuppressant. It increases the expression or changes...
    29 KB (3,309 words) - 04:27, 30 January 2024
  • Thumbnail for Siponimod
    on lymphocytes and other cell types. Siponimod may be very similar to fingolimod but preventing lymphopenia, one of its main side effects, by preventing...
    11 KB (798 words) - 14:37, 24 April 2024
  • Thumbnail for Sphingosine-1-phosphate receptor
    PMID 22264485. Groves, Aran; Kihara, Yasuyuki; Chun, Jerold (2013-05-15). "Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation...
    12 KB (1,266 words) - 08:05, 18 August 2023
  • Thumbnail for Etrasimod
    5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
    11 KB (682 words) - 03:02, 3 May 2024
  • Thumbnail for Sphingolipid
    Sphingosyl phosphatide Chun J, Hartung HP (2010). "Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis". Clinical Neuropharmacology. 33 (2): 91–101...
    24 KB (2,744 words) - 01:03, 10 January 2024
  • Thumbnail for Isaria sinclairii
    nymphs of cicadas. It produces myriocin, from which the synthetic drug fingolimod, a treatment for multiple sclerosis, was developed. Isaria sinclairii...
    8 KB (683 words) - 16:18, 10 January 2024
  • Filspari Filsuvez fimasartan (INN) Finacea (Bayer) finasteride (INN) fingolimod (USAN) Finlee Fioricet (Actavis) Fiorinal (Actavis) fipexide (INN) firategrast...
    2 KB (185 words) - 07:03, 27 December 2023
  • Thumbnail for Lysophosphatidylcholine
    5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
    11 KB (1,140 words) - 01:30, 25 March 2024
  • 5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
    24 KB (2,403 words) - 21:12, 4 March 2024
  • Olokizumab L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin L04AE01 Fingolimod L04AE02 Ozanimod L04AE03 Siponimod L04AE04 Ponesimod L04AE05 Etrasimod...
    3 KB (367 words) - 15:37, 25 January 2024
  • Thumbnail for Cotton wool spots
    history of relapsing forms of multiple sclerosis, after four years of using fingolimod (also known by its brand name Gilenya), another drug used to treat relapsing...
    20 KB (2,616 words) - 16:45, 29 April 2024
  • that certain immunosuppressants used to treat MS—such as interferon-β, fingolimod, natalizumab, and alemtuzumab—worsen NMO disease progression and should...
    68 KB (7,255 words) - 03:07, 5 February 2024
  • Deucravacitinib Efgartigimod alfa (+hyaluronidase) Etrasimod Filgotinib Fingolimod Guselkumab Iptacopan Itacitinib Ixekizumab Netakimab Olokizumab Ozanimod...
    7 KB (299 words) - 13:45, 27 April 2024
  • patient's quality of life. PRIMUS has been used to assess the efficacy of fingolimod and rivastigmine. Doward, LC; McKenna, S.P.; Meads, D.M.; Twiss, J; Eckert...
    7 KB (752 words) - 16:24, 3 December 2023
  • 5541 CYM-50260 CYM-50308 Dihydro-S1P (sphinganine 1-phosphate) Fingolimod Fingolimod phosphate KRP-203 Mocravimod Ozanimod Phyto-S1P Ponesimod RP-001...
    3 KB (328 words) - 13:29, 26 August 2023
  • Thumbnail for Ponesimod
    considered to be too low to be of clinical importance in a study. Like fingolimod, which is already approved for the treatment of multiple sclerosis, ponesimod...
    15 KB (1,066 words) - 05:36, 26 March 2024